Mary Kathryn(Duncan)MalecekMD

PubMed

• 233 citations
  Repurposing metformin for cancer treatment: current clinical studies
  Young Kwang Chae, Ayush Arya, Mary-Kate Malecek, Daniel Sanghoon Shin, Benedito A. Carneiro
  Oncotarget. 2016-03-19
• 51 citations
  Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
  Victor M. Orellana-Noia, Daniel R Reed, A. Mccook, Jeremy M Sen, Christian M Barlow
  Blood. 2021-09-27
• 3 citations
  Prognosis and risk stratification of peripheral T-cell lymphomas.
  Mary-Kate Malecek, Neha Mehta-Shah
  Seminars in Hematology. 2021-02-11

Abstracts/Posters

• Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine + Rituximab without Autologous Transplant
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcomes Following Early Relapse in Patients with Mantle Cell Lymphoma
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• North American Practice Patterns for PET-2 Positive Hodgkin Lymphoma
  Mary-Kate Malecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all